Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · February 14, 2024

Prognostic Role of Clinical Features and Selected Molecular Biomarkers in Patients With IDH-Mutant Astrocytoma

Acta Neuropathologica

 

Additional Info

Disclosure statements are available on the authors' profiles:

Acta Neuropathologica
Improved prognostic stratification of patients with isocitrate dehydrogenase-mutant astrocytoma
Acta Neuropathol. 2024 Jan 06;147(1)11, M Weller, J Felsberg, B Hentschel, D Gramatzki, N Kubon, M Wolter, M Reusche, P Roth, D Krex, U Herrlinger, M Westphal, JC Tonn, L Regli, CA Maurage, A von Deimling, T Pietsch, E Le Rhun, G Reifenberger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading